Recombinant Mouse EGF-like module-containing mucin-like hormone receptor-like 4 (Emr4)

Basic Research Information

• What is the molecular structure of mouse Emr4 and how does it differ from other EGF-TM7 family members?

Mouse Emr4 is a member of the EGF-TM7 family of adhesion-type class B 7-transmembrane receptors. The full-length mouse EMR4 cDNA encodes a predicted 689-amino acid protein with a distinctive structure including:

• Two epidermal growth factor (EGF)-like modules in the N-terminal region

• A mucin-like spacer domain

• A seven-transmembrane domain with a cytoplasmic tail

Unlike human EMR2 which contains five EGF-like domains, mouse EMR4 contains only two EGF-like modules . The protein undergoes proteolytic processing within the extracellular stalk region at the conserved G protein-coupled receptor (GPCR) proteolytic site, resulting in two protein subunits that remain associated noncovalently as a heterodimer .

Genetic mapping has established that mouse EMR4 is localized in the distal region of mouse chromosome 17 in close proximity to another EGF-TM7 gene, F4/80 (Emr1) .

• What is the expression pattern of Emr4 in mouse tissues and cell types?

Mouse EMR4 displays a predominantly leukocyte-restricted expression pattern, with significant cell-type specificity:

EMR4 expression is dynamically regulated during immune responses. It is up-regulated following macrophage activation in Biogel and thioglycollate-elicited peritoneal macrophages, as well as in TNF-α-treated resident peritoneal macrophages. Conversely, interleukin-4 and interleukin-10 dramatically reduce EMR4 expression .

Experimental Applications

• What are the recommended methods for expression and purification of recombinant mouse Emr4?

Recombinant mouse EMR4 can be successfully produced using several expression systems. Based on research protocols, the following methodological approach is recommended:

Bacterial Expression System:

• Construct a prokaryotic expression plasmid (e.g., pET28a/mEMR4) with a C-terminal His-tag

• Express in E. coli under optimal induction conditions

• Purify via nickel affinity chromatography

• Renature with GSH/GSSG system to ensure proper folding

Insect Cell Expression System:
For studies requiring post-translational modifications:

• Design a plasmid using state-of-the-art algorithm for gene synthesis

• Express in insect cells to allow for glycosylation and proper folding

• Purify using a multi-step, protein-specific process to ensure crystallization grade quality

Quality Control Parameters:

• Verify protein identity by SDS-PAGE and Western blot with anti-EMR4 antibodies

• Confirm purity (≥95%) using SDS-PAGE and SEC-HPLC

• Test for endotoxin levels (should be ≤0.1 ng per μg of protein)

• Validate biological activity through appropriate functional assays

• How can researchers design experimental studies to investigate Emr4 function in macrophage biology?

Designing robust experiments to study Emr4 function requires careful consideration of several methodological approaches:

Experimental Design Considerations:

• Variable Selection:

  • Independent variables: EMR4 expression levels, activation status of macrophages, cytokine treatments

  • Dependent variables: Cell migration, adhesion, cytokine production, interaction with B cells

  • Control variables: Cell culture conditions, genetic background of mice

• Knockout/Knockdown Approaches:

  • Generate EMR4-deficient macrophages using CRISPR-Cas9 or siRNA techniques

  • Compare functional outcomes between wild-type and EMR4-deficient cells

  • Complement with rescue experiments using recombinant EMR4

• Ligand Interaction Studies:

  • Use multivalent biotinylated EMR4-Fc fusion proteins as probes

  • Employ cell-binding assays to identify cellular ligands (e.g., on B lymphoma cell line A20)

  • Conduct Ca²⁺-dependency tests to characterize binding properties

Readout Methodologies:

• Flow cytometry to quantify EMR4 expression and binding to potential ligands

• Migration and adhesion assays to assess functional outcomes

• Cytokine production measurement to evaluate immunomodulatory effects

• What are the critical factors to consider when using recombinant Emr4 in immunological assays?

When using recombinant Emr4 in immunological assays, researchers should consider several critical factors:

Storage and Handling:

• Upon initial thawing, aliquot into polypropylene microtubes and freeze at -80°C

• For in vitro biological assays, dilute in sterile neutral buffer containing 1-2 mg/mL carrier protein

• For ELISA standards, use carrier protein concentrations of 5-10 mg/mL

• Avoid repeated freeze-thaw cycles to prevent loss of activity

Assay Optimization:

• For cell binding studies:

  • Add carrier proteins like mouse serum albumin (1-2 mg/mL) to prevent non-specific binding

  • Include appropriate negative controls (e.g., irrelevant recombinant proteins of similar size)

  • Consider using Mouse BD Fc Block™ to prevent Fc receptor-mediated binding

• For functional assays:

  • Determine optimal concentration range through dose-response experiments

  • Include positive controls (e.g., known activators of target cells)

  • Account for potential endotoxin contamination by using endotoxin-free reagents

Advanced Research Questions

• How does the proteolytic processing of Emr4 affect its function, and what techniques can be used to study this phenomenon?

Emr4 undergoes proteolytic processing at the GPCR proteolytic site in the extracellular region, resulting in a heterodimeric structure. This processing is critical for function and can be studied through various approaches:

Impact of Proteolytic Processing:

• Creates two protein subunits that remain non-covalently associated

• May regulate receptor activation and signaling

• Potentially controls interaction with ligands on B lymphocytes

Methodological Approaches to Study Processing:

• Site-directed mutagenesis:

  • Mutate the identified cleavage site to generate processing-deficient variants

  • Compare biological activities of wild-type and mutant proteins

  • Assess impact on cellular localization and ligand binding

• Biochemical characterization:

  • Use N-terminal amino acid sequencing to precisely identify cleavage sites

  • Apply protease inhibitors to assess the role of specific proteases

  • Employ mass spectrometry to characterize processed forms

• Imaging techniques:

  • Use fluorescently tagged Emr4 variants to track processing in living cells

  • Apply FRET-based approaches to monitor conformational changes upon processing

  • Implement super-resolution microscopy to visualize receptor distribution

• What are the known ligand interactions of mouse Emr4, and how do they compare with other EGF-TM7 family members?

Mouse Emr4 has been shown to interact with specific cellular ligands, with distinct characteristics compared to other family members:

Ligand Characteristics:

• A putative cell surface ligand has been identified on the B lymphoma cell line A20

• The Emr4-ligand interaction is Ca²⁺-independent

• This interaction is mediated predominantly by the second EGF-like module

Comparison with Other EGF-TM7 Members:

Methodological Approaches for Ligand Studies:

• Use recombinant soluble EMR4 multivalent probes to detect ligands on different cell types

• Apply blocking antibodies to verify specificity of interactions

• Conduct domain-swap experiments to identify critical binding regions

• Implement surface plasmon resonance to quantify binding kinetics

• What are the contradictions and knowledge gaps in current Emr4 research, and how might they be addressed?

Several contradictions and knowledge gaps exist in the current understanding of Emr4:

Contradictions:

• Expression pattern discrepancies:

  • Some studies report expression restricted to resident macrophages

  • Others detect expression in neutrophils and dendritic cells

  • Resolution approach: Single-cell RNA sequencing to definitively map expression across immune cell populations

• Functional significance:

  • Limited evidence for physiological relevance of Emr4-mediated interactions

  • Unclear how Emr4 contributes to macrophage function in vivo

  • Resolution approach: Generate tissue-specific conditional knockout mice to study function in different contexts

Knowledge Gaps:

• Signaling pathways:

  • Limited understanding of downstream signaling cascades

  • Unknown G-protein coupling preferences

  • Research approach: Phosphoproteomic analysis following receptor activation

• Evolution and conservation:

  • Relationship between mouse Emr4 and human EMR family members not fully characterized

  • Research approach: Comparative genomic and structural studies across species

• Disease relevance:

  • Potential roles in inflammatory or immune disorders unexplored

  • Research approach: Analysis of Emr4 expression and function in disease models

Practical Applications

• How can recombinant Emr4 be effectively used in immunological research beyond binding studies?

Recombinant Emr4 can serve multiple purposes in immunological research:

Therapeutic Potential Assessment:

• Use as a competitive inhibitor of native Emr4-ligand interactions

• Evaluate effects on macrophage-B cell communication

• Assess impact on inflammatory responses in ex vivo tissue cultures

Antibody Generation:

• Immunize with recombinant protein to generate monoclonal antibodies

• Validate antibodies using flow cytometry, Western blotting, and immunoprecipitation

• Apply antibodies to study endogenous Emr4 expression and function

Co-culture Systems:

• Develop in vitro systems to study Emr4-mediated cellular interactions

• Use recombinant protein to block interactions and assess functional consequences

• Implement time-lapse microscopy to visualize dynamic cellular interactions

• What experimental strategies can researchers employ to study the role of Emr4 in macrophage activation and polarization?

To investigate Emr4's role in macrophage activation and polarization, researchers can implement several experimental strategies:

In Vitro Approaches:

• Stimulation Experiments:

  • Treat macrophages with various polarizing stimuli (M1: IFN-γ, LPS; M2: IL-4, IL-10)

  • Measure changes in Emr4 expression by flow cytometry and qRT-PCR

  • Correlate Emr4 levels with polarization markers

• Gain/Loss of Function Studies:

  • Overexpress or silence Emr4 in macrophage cell lines

  • Assess impact on polarization marker expression

  • Evaluate functional consequences (phagocytosis, cytokine production)

Ex Vivo Approaches:

• Primary Cell Isolation:

  • Isolate macrophages from different tissues of wild-type and Emr4-deficient mice

  • Compare polarization potential and responses to stimuli

  • Analyze transcriptional profiles by RNA sequencing

• Co-culture Systems:

  • Establish co-cultures of macrophages with B cells

  • Block Emr4-ligand interactions using recombinant proteins or antibodies

  • Assess impact on macrophage polarization and B cell responses

Data Analysis Frameworks:

• Apply multivariate analysis to identify correlations between Emr4 expression and polarization markers

• Use principal component analysis to visualize macrophage polarization states

• Implement machine learning approaches to predict Emr4 function based on expression patterns